Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...

Descripció completa

Dades bibliogràfiques
Autors principals:	Eleonora M. Lad, Robert P. Finger, Robyn Guymer
Format:	Article
Idioma:	English
Publicat:	Adis, Springer Healthcare 2023-09-01
Col·lecció:	Ophthalmology and Therapy
Matèries:	Age-related macular degeneration Biomarkers iAMD Geographic atrophy Neovascular AMD
Accés en línia:	https://doi.org/10.1007/s40123-023-00807-9

Ítems similars

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
per: Treefa Shwani, et al.
Publicat: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
per: İmren Akkoyun
Publicat: (2014-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
per: Reem H. ElSheikh, et al.
Publicat: (2022-11-01)

Serum lipids in adults with late age-related macular degeneration: a case-control study
per: Richard D. Semba, et al.
Publicat: (2019-01-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
per: João Estarreja, et al.
Publicat: (2024-07-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
per: Julia Nguyen, et al.
Publicat: (2024-02-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
per: Sonali Nashine
Publicat: (2021-09-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
per: Răzvan Vasile ROPCIUC
Publicat: (2024-05-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
per: Kiruthika M, et al.
Publicat: (2025-02-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
per: Anat Loewenstein, et al.
Publicat: (2024-12-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
per: Niloofar Piri, et al.
Publicat: (2023-05-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
per: Grace A. Borchert, et al.
Publicat: (2023-08-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
per: M. M. Bikbov, et al.
Publicat: (2022-03-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
per: Ines Lains, MD, PhD, et al.
Publicat: (2024-01-01)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
per: Nicola Ferrante, et al.
Publicat: (2022-04-01)

Early and intermediate age-related macular degeneration: update and clinical review
per: García-Layana A, et al.
Publicat: (2017-10-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
per: Elżbieta Nowak, et al.
Publicat: (2018-07-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
per: Ashwin Gupta, et al.
Publicat: (2022-01-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
per: Yujong Yi, et al.
Publicat: (2024-03-01)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
per: Sabrina L. Mitchell, et al.
Publicat: (2021-11-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
per: Audrey Yan, et al.
Publicat: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
per: Mayank Choubey, et al.
Publicat: (2023-11-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
per: Sanjay Kumar Mishra, et al.
Publicat: (2022-07-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
per: Uday Pratap Singh Parmar, et al.
Publicat: (2025-01-01)

Genetic Insights into Age-Related Macular Degeneration
per: Bhumika, et al.
Publicat: (2024-07-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
per: Shashikant Sharma, et al.
Publicat: (2021-03-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
per: Rita Flores, et al.
Publicat: (2021-12-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
per: Xiang Li, et al.
Publicat: (2024-12-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
per: Zofia Ulańczyk, et al.
Publicat: (2020-10-01)

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
per: Mateusz Winiarczyk, et al.
Publicat: (2024-05-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
per: Saurav Mallik, et al.
Publicat: (2022-06-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
per: Ngoc Thien Le, et al.
Publicat: (2023-12-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
per: S. V. Yanchenko, et al.
Publicat: (2023-01-01)

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
per: Ramandeep Singh, et al.
Publicat: (2022-01-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
per: Yingbin Fu, et al.
Publicat: (2024-02-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
per: Avaylon J, et al.
Publicat: (2020-05-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
per: Enoch T. Peng, et al.
Publicat: (2023-05-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
per: Karanvir Gill, et al.
Publicat: (2024-07-01)

Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series
per: Silvio Zuccarini, et al.
Publicat: (2022-03-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
per: Elliott H. Sohn, MD, et al.
Publicat: (2021-03-01)